Showing results (1011-1020 of 1,026) with videos related to

Sort By:
Pageof 103
Viruses|December 24, 2014
Phocine distemper virus: current knowledge and future directionsPádraig J Duignan, Marie-Françoise Van Bressem, Jason D Baker, et al.
Frontiers in Immunology|July 30, 2025
Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal studyCamila Amormino Corsini, Guilherme Rodrigues Fernandes Campos, Priscila Fernanda da Silva Martins, et al.
Frontiers in Immunology|June 27, 2022
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 StudyRafaella F Q Grenfell, Nathalie B F Almeida, Priscilla S Filgueiras, et al.
The Lancet. Infectious Diseases|August 9, 2025
Dynamics of endemic virus re-emergence in children in the USA following the COVID-19 pandemic (2022-23): a prospective, multicentre, longitudinal, immunoepidemiological surveillance studyHai Nguyen-Tran, Sang Woo Park, Matthew R Vogt, et al.
Open Forum Infectious Diseases|July 27, 2023
Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post Hoc AnalysisAmy Legg, Matthew A Roberts, Jane Davies, et al.
The Medical Journal of Australia|May 2, 2021
Australia in 2030: what is our path to health for all?Kathryn Backholer, Fran Baum, Summer M Finlay, et al.
Journal of Virology|June 19, 2015
Phylodynamics of Enterovirus A71-Associated Hand, Foot, and Mouth Disease in Viet NamJemma L Geoghegan, Le Van Tan, Denise Kühnert, et al.
Scientific Reports|July 2, 2025
Immunogenicity and safety of CoronaVac vaccine in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow upCamila Amormino Corsini, Priscila Fernanda da Silva Martins, Priscilla Soares Filgueiras, et al.
Research Square|March 11, 2024
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow upCamila Amormino Corsini, Priscila Fernanda da Silva Martins, Priscilla Soares Filgueiras, et al.
Nature Communications|May 24, 2012
Gene-associated markers provide tools for tackling illegal fishing and false eco-certificationEinar E Nielsen, Alessia Cariani, Eoin Mac Aoidh, et al.
Pageof 103